Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Wiskott-Aldrich syndrome is an inherited X-linked
immunodeficiency
characterized by thrombocytopenia, eczema, and a tendency toward lymphoid malignancy. Lymphocytes from affected individuals have cytoskeletal abnormalities, and monocytes show impaired motility. The Wiskott-Aldrich syndrome protein (WASP) is a multi-domain protein involved in cytoskeletal organization. In a two-hybrid screen, we identified the protein
Cdc42-interacting protein 4
(
CIP4
) as a WASP interactor.
CIP4
, like WASP, is a Cdc42 effector protein involved in cytoskeletal organization. We found that the WASP-
CIP4
interaction is mediated by the binding of the Src homology 3 domain of
CIP4
to the proline-rich segment of WASP. Cdc42 was not required for this interaction. Co-expression of
CIP4
and green fluorescent protein-WASP in COS-7 cells led to the association of WASP with microtubules. In vitro experiments showed that
CIP4
binds to microtubules via its NH(2) terminus. The region of
CIP4
responsible for binding to active Cdc42 was localized to amino acids 383-417, and the mutation I398S abrogated binding. Deletion of the Cdc42-binding domain of
CIP4
did not affect the colocalization of WASP with microtubules in vivo. We conclude that
CIP4
can mediate the association of WASP with microtubules. This may facilitate transport of WASP to sites of substrate adhesion in hematopoietic cells.
...
PMID:Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. 1071